Kuehl F A, Humes J L, Beveridge G C, Van Arman C G, Egan R W
Inflammation. 1977 Dec;2(4):285-94. doi: 10.1007/BF00921008.
The causal role assigned to the E and F prostaglandins in inflammatory processes, implied by the antiinflammatory action of prostaglandin synthetase inhibitors, is not consistent with the findings reported here that a compound (MK-447) capable of increasing levels of these prostaglandins is antiinflammatory in classical animal models of acute inflammation. That both MK-447 and prostaglandin synthetase inhibitors depress the enzymatic formation of PGG2 from arachidonic acid suggests that this endoperoxide plays a pivotal role in acute inflammation. However, in view of the intermediate nature of PGG2, it seems likely that such a pivotal role for this substance is a function of its ability to be converted to other inflammatory mediators. Possible candidates for a causal role are thromboxane A2 (TXA2) prostacyclin (PGI2), both of which derive from PGG2. However, direct evidence is presented to show that an oxygen equivalent released in the enzymatic conversion of PGG2 to PGH2 is a prime factor in inflammation.
前列腺素合成酶抑制剂的抗炎作用所暗示的、赋予E和F前列腺素在炎症过程中的因果作用,与本文报道的结果不一致,即在经典的急性炎症动物模型中,一种能够提高这些前列腺素水平的化合物(MK - 447)具有抗炎作用。MK - 447和前列腺素合成酶抑制剂都能抑制花生四烯酸生成PGG2的酶促反应,这表明这种内过氧化物在急性炎症中起关键作用。然而,鉴于PGG2的中间性质,这种物质的关键作用似乎是其转化为其他炎症介质能力的一种功能。可能具有因果作用的候选物质是血栓素A2(TXA2)和前列环素(PGI2),它们都来源于PGG2。然而,有直接证据表明,PGG2酶促转化为PGH2过程中释放的一个氧等价物是炎症的主要因素。